Show simple item record

dc.contributor.authorMoraes, J.C. dees_ES
dc.contributor.authorLeón, María Elenaes_ES
dc.contributor.authorSouza, Vanda Akico Ueda Fick dees_ES
dc.contributor.authorPannuti, Ces_ES
dc.contributor.authorTravisanello, Ces_ES
dc.contributor.authorHalsey, N.Aes_ES
dc.contributor.authorQuadros, Ciro .A. dees_ES
dc.date.accessioned2016
dc.date.available2016
dc.date.issued1994es_ES
dc.identifier.urihttps://iris.paho.org/handle/10665.2/26929
dc.description.abstractThe aim of the study reported here was to determine if bifurcated needles or multiple puncture cylinders would prove suitable for administation of measles vaccines. Children 9 to 11 months old in Sao Paulo, Brazil, were assigned to receive either Biken-Cam 70 (5 000 TCID 50/0.5 ml) or Edmonston-Zagreb (7 000 TCID 50/0.5 ml) measles vaccine intradermally with a bifurcated needle or a multiple puncture cylinder. These devices are usually used to administer smallpox of BCG vaccine. The volume of vaccine inoculated was aproximately 0.003 ml. Measles IgG antibodies were measured by enzyme-linked immunosorbent assay (ELISA) at the time of vaccination and 8 week later. The study participants were examined 14 days after inoculation for possible adverse reactions. Overall, the children's average age was 9.5 + 0.66 months at vaccination. None of the 45 recipiests of Biken-Cam vaccine responded serologically. The 49 Edmonston-Zagreb vaccine recipients immunized with the multiple puncture cylinder had a somewhat higher serologic response rate (35 percent) and mean concentration of measles antibodies ( 323 mIU/ml) than those 51 who received the same vaccine administered with the bifurcated needle (26 percent and 291 mIU/ml, respectively). The rates of reported symptoms after vaccination did not differ significantly among the groups. Overall, the low serologic response rates following intradermal immunization with the devices tested in this study indicate that this route of administration is not suitable for routine administration of standard-titer vaccinesen_US
dc.description.abstractThis article will also be published in Spanish in the BOSP. Vol. 118, 1995en_US
dc.format.extent18es_ES
dc.relation.ispartofseriesBulletin of the Pan American Health Organization (PAHO);28(3),sept. 1994en_US
dc.subjectMeasleses_ES
dc.subjectMeasles Vaccinees_ES
dc.subjectInjections, Intradermales_ES
dc.subjectBrazilen_US
dc.titleIntradermal administration of measles vaccineses_ES
dc.typeJournal articlesen_US
dc.rights.holderPan American Health Organizationen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record